Montagne (2008). Drugs on the Internet. I: Introduction and web sites on psychedelic drugs. Substance Use & Misuse.
Morris (2008). Research on psychedelics moves into the mainstream. The Lancet.
Nicotra (2008). William James in the Borderlands: Psychedelic Science and the "Accidental Fences" of Self. Configurations.
Sessa (2008). Is it time to revisit the role of psychedelic drugs in enhancing human creativity? Journal of Psychopharmacology.
Sessa (2008). Are psychedelic drug treatments seeing a comeback in psychiatry? Progress in Neurology and Psychiatry.
Slattery (2008). Psychedelics: My problem discourse. Configurations.
Wu et al. (2008). Hallucinogen use disorders among adult users of MDMA and other hallucinogens. American Journal on Addictions.
Zieger (2008). Victorian Hallucinogens. Romanticism and Victorianism on the Net.
Abbas et al. (2009). PSD-95 is essential for hallucinogen and atypical antipsychotic drug actions at serotonin receptors. The Journal of Neuroscience.
Albertson & Grubbs (2009). Subjective effects of Salvia divinorum: LSD- or marijuana-like? Journal of Psychoactive Drugs.
Capriles (2009). Beyond mind III: Further steps to a metatranspersonal philosophy and psychology (Continuation of the discussion on the three best known transpersonal paradigms, with a focus on Washburn and Grof). International Journal of Transpersonal Studies.
Chang et al. (2009). Towards a quantitative representation of the cell signaling mechanisms of hallucinogens: measurement and mathematical modeling of 5-HT1A and 5-HT2A receptor-mediated ERK1/2 activation. Neuropharmacology.
Chaturvedi (2009). Can endogenous hallucinogens explain recurrence of hallucinations? Medical Hypotheses.
Curran et al. (2009). Modelling psychosis. Psychopharmacology.
Danforth (2009). Focusing-oriented psychotherapy as a supplement to preparation for psychedelic therapy. Journal of Transpersonal Psychology.
Dyck (2009). Prairies, psychedelics and place: the dynamics of region in psychiatric research. Health & Place.
González-Maeso & Sealfon (2009). Psychedelics and schizophrenia. Trends in Neurosciences.
Khorana et al. (2009). Effect of 8-hydroxy-2-( N, N-di- n-propylamino)tetralin and MDMA on the discriminative stimulus effects of the classical hallucinogen DOM in rats. Pharmacology, Biochemistry and Behavior.
Marek (2009). Activation of adenosine1 (A1) receptors suppresses head shakes induced by a serotonergic hallucinogen in rats. Neuropharmacology.
Mold (2009). Psychedelic Psychiatry: LSD From Clinic to Campus (Book Review). Social History of Medicine.
Nakhaee et al. (2009). Knowledge of dentistry, medicine, and pharmacy students about psychedelic drugs in Kerman University of Medical Sciences. Addiction & Health.
Opaleye et al. (2009). Recreational use of benzydamine as a hallucinogen among street youth in Brazil. Revista Brasileira de Psiquiatria.
Richards (2009). The rebirth of research with entheogens: Lessons from the past and hypotheses for the future. Journal of Transpersonal Psychology.
Schroll et al. (2009). Reflections on transpersonal psychology's 40th anniversary, ecopsychology, transpersonal science, and psychedelics: A conversation forum. International Journal of Transpersonal Studies.
Shorter (2009). Psychedelic Psychiatry: LSD from Clinic to Campus (Book Review). The American Historical Review.
St. John (2009). Neotrance and the psychedelic festival. Dancecult: Journal of Electronic Dance Music Culture.
Wallach (2009). Endogenous hallucinogens as ligands of the trace amine receptors: A possible role in sensory perception. Medical Hypotheses.
Wilson & Widom (2009). A prospective examination of the path from child abuse and neglect to illicit drug use in middle adulthood: The potential mediating role of four risk factors. Journal of Youth and Adolescence.
Wu et al. (2009). Hallucinogen-related disorders in a national sample of adolescents: The influence of ecstasy/MDMA use. Drug and Alcohol Dependence.
Adams (2010). Psychedelics and holistic thinking: a tool for science. Drugs and Alcohol Today.
Canal et al. (2010). The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen. Psychopharmacology.
Carstairs (2010). Psychedelic psychiatry: LSD from clinic to campus. Medical History.
Díaz (2010). Sacred plants and visionary consciousness. Phenomenology and the Cognitive Sciences.
Doering-Silveira et al. (2010). Adolescents using hallucinogens within a religious context: a neuropsychological assessment. European Psychiatry.
Healy (2010). Psychedelic Psychiatry: LSD from Clinic to Campus (review). Bulletin of the History of Medicine.
Karst et al. (2010). The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: An open, non-randomized case series. Cephalalgia.
Kroker (2010). Psychedelic psychiatry: LSD from clinic to campus. Canadian Bulletin of Medical History.
Lancet Oncology (2010). Cancer and hallucinogens: a long, strange trip. Lancet Oncology.
Langlitz (2010). The persistence of the subjective in neuropsychopharmacology: observations of contemporary hallucinogen research. History of the Human Sciences.
Matthew et al. (2010). Investigating the mechanisms of hallucinogen-induced visions using 3,4-methylenedioxyamphetamine (MDA): a randomized controlled trial in humans. PLoS ONE.
Mills (2010). Hallucinogens as hard science: the adrenochrome hypothesis for the biogenesis of schizophrenia. History of Psychology.
Palenicek et al. (2010). The role of serotonin and dopamine systems in the action of the psychedelic 4-bromo-2,5-dimethoxyphenylethylamine (2C-B). European Neuropsychopharmacology.
Sergi et al. (2010). Micro-solid phase extraction coupled with high-performance liquid chromatography–tandem mass spectrometry for the determination of stimulants, hallucinogens, ketamine and phencyclidine in oral fluids. Analytica Chimica Acta.
Smith et al. (2010). Crystallographic characterization of the first reported crystalline form of the potent hallucinogen (R)-2-amino-1-(8-bromobenzo1,2-b;5,4-b'difuran-4-yl)propane or 'bromodragonfly': the 1:1 anhydrous proton-transfer compound with 3,5-dinitrosalicylic acid. Acta crystallographica.
Vollenweider & Kometer (2010). The neurobiology of psychedelic drugs: Implications for the treatment of mood disorders. Nature Reviews Neuroscience.
Wu et al. (2010). An item response theory analysis of DSM-IV criteria for hallucinogen abuse and dependence in adolescents. Addictive Behaviors.
Alyushin (2011). Psychedelic experience as a heuristic tool for exploring the mind and the brain. NeuroQuantology.
Baggott et al. (2011). Abnormal visual experiences in individuals with histories of hallucinogen use: a Web-based questionnaire. Drug and Alcohol Dependence.
Carhart-Harris et al. (2011). The functional brain correlates of the psychedelic state: an arterial spin labelling study with psilocybin. European Neuropsychopharmacology.
Erritzoe et al. (2011). In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and hallucinogen users. Archives of General Psychiatry.
Grass (2011). Biophotons, hallucinogens, and fluorescence. European Psychiatry.
Kerridge et al. (2011). Dimensionality of hallucinogen and inhalant/solvent abuse and dependence criteria: Implications for the diagnostic and statistical manual of mental disorders—Fifth edition. Addictive Behaviors.
Kuzenko et al. (2011). Associations between use of cocaine, amphetamines, or psychedelics and psychotic symptoms in a community sample. Acta Psychiatrica Scandinavica.
Móró et al. (2011). Voice of the psychonauts: coping, life purpose, and spirituality in psychedelic drug users. Journal of Psychoactive Drugs.
Nichols (2011). Legal highs: the dark side of medicinal chemistry: synthetic chemist David Nichols describes how his research on psychedelic compounds has been abused--with fatal consequences. (WORLD VIEW: A personal take on events). Nature.
Walsh (2011). Drugs, the Internet and change. Journal of Psychoactive Drugs.
Wesson et al. (2011). Psychedelic drugs, hippie counterculture, speed and phenobarbital treatment of sedative-hypnotic dependence: a journey to the Haight Ashbury in the Sixties. Journal of Psychoactive Drugs.
Akst (2012). Psychedelic fervor. The Scientist.
Anderson et al. (2012). Ayahuasca as antidepressant? Psychedelics and styles of reasoning in psychiatry. Anthropology of Consciousness.
Carhart-Harris et al. (2012). Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin. The British Journal of Psychiatry.
Carhart-Harris et al. (2012). Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. PNAS.
Dutta (2012). Repression of death consciousness and the psychedelic trip. Journal of Cancer Research and Therapeutics.
Halberstadt et al. (2012). Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice. Journal of Psychopharmacology.
Harner (2012). My path in shamanism. International Journal of Transpersonal Studies.
Hermle et al. (2012). Hallucinogen-persisting perception disorder. Therapeutic Advances in Psychopharmacology.
Kilpatrick & Bard (2012). Hallucinogen persisting perception disorder in neuronal networks with adaptation. Journal of Computational Neuroscience.
Lee & Roth (2012). Hallucinogen actions on human brain revealed. PNAS.
Licht et al. (2012). Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases. Human Psychopharmacology.
Odden (2012). Alcohol, tobacco, marijuana and hallucinogen use in Samoan adolescents. Drug and Alcohol Review.
Ross (2012). Serotonergic hallucinogens and emerging targets for addiction pharmacotherapies. The Psychiatric clinics of North America.
Sayin (2012). A comparative review of the neuro-psychopharmacology of hallucinogen-induced altered states of consciousness: The uniqueness of some hallucinogens. NeuroQuantology.
Sessa (2012). Shaping the renaissance of psychedelic research. The Lancet.
Barrau-Alonso et al. (2013). Psychedelic drugs in psychotherapy. A revival? European Psychiatry.
Benekareddy et al. (2013). Induction of the plasticity-associated immediate early gene Arc by stress and hallucinogens: role of brain-derived neurotrophic factor. The International Journal of Neuropsychopharmacology.
Burdick & Adinoff (2013). A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment. The American Journal of Drug and Alcohol Abuse.
Carhart-Harris (2013). Psychedelic drugs, magical thinking and psychosis. Journal of Neurology, Neurosurgery and Psychiatry.
Corbin (2013). Psychedelic sciences writ small and large. BioSocieties.
Corbin (2013). Tactics of legitimation in the psychedelic sciences: Lessons for feminist sociology of knowledge. American Behavioral Scientist.
Elcock (2013). From Acid Revolution to Entheogenic Evolution: psychedelic philosophy in the sixties and beyond: Winner of the William M. Jones Best Graduate Student Paper Award at the 2013 American Culture Association Conference. Journal of American Culture.
Goda et al. (2013). Serotonergic hallucinogens differentially modify gamma and high frequency oscillations in the rat nucleus accumbens. Psychopharmacology
Halberstadt & Geyer (2013). Serotonergic hallucinogens as translational models relevant to schizophrenia. The International Journal of Neuropsychopharmacology.